<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>It is currently unknown whether immunosuppressive therapy or hematopoietic stem cell transplantation is the most appropriate treatment strategy for children with refractory cytopenia and <z:mpath ids='MPATH_458'>normal</z:mpath> karyotype or <z:mp ids='MP_0004027'>trisomy</z:mp> 8 </plain></SENT>
<SENT sid="1" pm="."><plain>We report on 31 children with hypoplastic refractory cytopenia treated with immunosuppressive therapy consisting of antithymocyte globulin and <z:chebi fb="0" ids="4031">cyclosporine</z:chebi> </plain></SENT>
<SENT sid="2" pm="."><plain>At 6 months, 22 of 29 evaluable patients had a complete or partial response; a total of ten patients achieved a complete response at varying time points </plain></SENT>
<SENT sid="3" pm="."><plain>Six patients subsequently received a transplant because of non-response, progression to advanced <z:hpo ids='HP_0002863'>myelodysplastic syndrome</z:hpo> or evolution of <z:mp ids='MP_0004026'>monosomy</z:mp> 7 </plain></SENT>
<SENT sid="4" pm="."><plain>Overall and failure-free survival rates at 3 years were 88% and 57%, respectively </plain></SENT>
</text></document>